![N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide structure](/static/products/5670/56707-82-5.webp)
N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide
TL;DR: N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide (CAS 56707-82-5) is a chemical compound with molecular formula C13H15ClN4O5 and molecular weight 342.07 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide
Also Known As: N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide, N-Acetyl-7-chloro-3-pentofuranosyl-3H-imidazo[4,5-b]pyridin-5-amine
| Molecular Formula | C13H15ClN4O5 |
|---|---|
| Molecular Weight | 342.07 g/mol |
| LogP | 0.1 |
| Topological Polar Surface Area | 130.0 Ų |
| Hydrogen Bond Donors | 4 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Exact Mass | 342.0731 |
| Heavy Atoms | 23 |
| Complexity | 458.0 |
Chemical Identifiers
| CAS Number | 56707-82-5 |
|---|---|
| SMILES | CC(=O)NC1=NC2=C(C(=C1)Cl)N=CN2C3C(C(C(O3)CO)O)O |
| InChIKey | DYPLTHHPGXDPMA-UHFFFAOYSA-N |
Product Overview
N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide (CAS 56707-82-5), with molecular formula C13H15ClN4O5 and molecular weight 342.07 g/mol. IUPAC: N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide.
Chemical Property Profile of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide
Property Insights of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide
The XLogP value of 0.1 suggests moderate lipophilicity, balancing water solubility and membrane permeability for N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide. The TPSA of 130.0 Ų falls within the moderate polarity range, balancing permeability and solubility for N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide. Following Lipinski's Rule of Five, N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide has 4 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide?
The CAS number of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide is 56707-82-5.
What is the molecular formula of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide?
The molecular formula of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide is C13H15ClN4O5.
What is the molecular weight of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide?
The molecular weight of N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide is 342.07 g/mol.
Where can I buy N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide?
You can request a quote for N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide?
Yes, KEHONG BIO provides custom synthesis services for N-[7-chloro-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[4,5-b]pyridin-5-yl]acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.